DCP
AGN

DSM Capital Partners’s Allergan plc AGN Stock Holding History

DSM Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-418,246
Closed -$85.7M – 46
2017
Q3 		$85.7M Buy
418,246
+93,602
+29% +$21.8M 1.22% 25
2017
Q2 		$78.9M Sell
324,644
-427,265
-57% -$100M 1.17% 25
2017
Q1 		$180M Sell
751,909
-491,342
-40% -$114M 2.93% 15
2016
Q4 		$261M Sell
1,243,251
-323,921
-21% -$67.1M 4.51% 7
2016
Q3 		$361M Sell
1,567,172
-119,737
-7% -$29.3M 5.82% 4
2016
Q2 		$390M Buy
1,686,909
+149,316
+10% +$34.4M 6.71% 2
2016
Q1 		$412M Sell
1,537,593
-9,940
-0.6% -$2.85M 6.76% 2
2015
Q4 		$484M Buy
1,547,533
+296,391
+24% +$88.2M 7.58% 1
2015
Q3 		$340M Buy
1,251,142
+120,085
+11% +$36.9M 6.33% 2
2015
Q2 		$343M Buy
1,131,057
+92,456
+9% +$27.6M 5.86% 4
2015
Q1 		$309M Buy
+1,038,601
New +$296M 5.3% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

DSM Capital Partners's AGN Position: Q4 2017 in Review

DSM Capital Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 418,246 shares — an estimated $85.7M sold.

DSM Capital Partners first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $484M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • DSM Capital Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • DSM Capital Partners sold 418,246 Allergan plc shares in Q4 2017, an estimated $85.7M.
  • DSM Capital Partners first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • DSM Capital Partners's Allergan plc position peaked at $484M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on DSM Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.